MeSH tree: C10.228.662.262
Huntington's disease is caused by repetitive "stutters" in DNA—specifically repeated CAG sequences—that expand abnormally over time, leading to toxic protein accumulation that contributes to the progression of the disease. ...
Oct 22, 2026
0
6
A new study has revealed why some people with Huntington's disease develop symptoms 10–12 years earlier and experience a more aggressive form of the disease.
Sep 14, 2026
0
15
A region of the brain called the striatum is critical for many cognitive and motor functions, including decision-making, movement control, habit formation and reward processing. It also plays a role in addiction and is significantly ...
Sep 1, 2026
0
10
New treatments for Huntington's disease could be on the horizon following research led by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab).
Aug 17, 2026
0
18
Researchers have shown that an imaging model can detect microstructural abnormalities in the brain associated with Huntington's disease, potentially offering a new method for monitoring disease progression and evaluating ...
Aug 11, 2026
0
7
A gene-editing tool designed to precisely rewrite the gene that causes Huntington's disease reduced toxic protein fragments and symptoms associated with the disease in mice, researchers at the University of Illinois Urbana-Champaign ...
Jul 29, 2026
0
7
New genetic risk factors have been identified for fibromyalgia syndrome in a landmark study that involved scientists at King's College London. The study, published in Nature Medicine, highlights how the nervous system plays ...
Jul 28, 2026
0
62
Motor issues—such as coordination problems, motor slowing or sudden, uncontrolled movements—have been recognized as signs of psychological disorders since the 1800s. How they map to mental health conditions, however, remains ...
Jul 23, 2026
0
4
For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen. Walking can become slower and balance more uncertain. The most effective treatment remains ...
Jul 15, 2026
0
8
An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents ...
Jul 9, 2026
0
7
